{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:59:30Z","timestamp":1780775970076,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejso.2024.107980","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T12:48:26Z","timestamp":1706014106000},"page":"107980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7498-0724","authenticated-orcid":false,"given":"Masaaki","family":"Kagoura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motokazu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Gotohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.107980_bib1","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/CMAR.S157092","article-title":"Biliary tract cancers: current knowledge, clinical candidates and future challenges","volume":"11","author":"Tariq","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2024.107980_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4143\/crt.2014.308","article-title":"Gemcitabine plus cisplatin for advanced biliary tract cancer: a systematic review","volume":"47","author":"Park","year":"2015","journal-title":"Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejso.2024.107980_bib3","article-title":"Current targeted therapy options in the treatment of cholangiocarcinoma: a literature review","volume":"14","author":"Proskuriakova","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ejso.2024.107980_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.107980_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.107980_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","article-title":"Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial","volume":"15","author":"Stein","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2024.107980_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bjs.10776","article-title":"Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer","volume":"105","author":"Ebata","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2024.107980_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2024.107980_bib9","article-title":"A\u00a0multicenter survey on eligibility for a randomized, phase III trial of adjuvant chemotherapy for resected biliary tract cancer (JCOG1202, ASCOT)","author":"Kobayashi","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.107980_bib10","article-title":"ASO author reflections: characteristics of surgery for biliary tract cancer that should be considered during the design of future clinical trials","author":"Kobayashi","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.107980_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jhbp.314","article-title":"Biliary tract cancer registry in Japan from 2008 to 2013","volume":"23","author":"Ishihara","year":"2016","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.ejso.2024.107980_bib12","series-title":"TNM classification of malignant tumors","year":"2009"},{"key":"10.1016\/j.ejso.2024.107980_bib13","series-title":"TNM classification of malignant tumors","year":"2016"},{"key":"10.1016\/j.ejso.2024.107980_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4143\/crt.2017.595","article-title":"Validation of the eighth American joint committee on cancer staging system for distal bile duct carcinoma","volume":"51","author":"Jun","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ejso.2024.107980_bib15","series-title":"Digestive system tumours","article-title":"WHO classification of tumours editorial board editor","author":"Nakanuma","year":"2019"},{"key":"10.1016\/j.ejso.2024.107980_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejso.2024.107980_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0036-1571835","article-title":"Mechanisms of perineural invasion","volume":"77","author":"Bakst","year":"2016","journal-title":"J\u00a0Neurol Surg B Skull Base"},{"key":"10.1016\/j.ejso.2024.107980_bib18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/000348948509400420","article-title":"Nerves and neurotropic carcinomas","volume":"94","author":"Batsakis","year":"1985","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ejso.2024.107980_bib19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1288\/00005537-198610000-00015","article-title":"Prognostic implications of perineural spread in squamous carcinomas of the head and neck","volume":"96","author":"Soo","year":"1986","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejso.2024.107980_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archotol.124.6.637","article-title":"Perineural invasion in squamous cell carcinoma of the head and neck","volume":"124","author":"Fagan","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ejso.2024.107980_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1096-9098(199707)65:3<164::AID-JSO4>3.0.CO;2-4","article-title":"Perineural invasion by ductal adenocarcinoma of the pancreas","volume":"65","author":"Takahashi","year":"1997","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2024.107980_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/XCS.0000000000000299","article-title":"Lymph node ratio nomogram-based prognostic model for resected distal cholangiocarcinoma","volume":"235","author":"Perez","year":"2022","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2024.107980_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/bjs.10452","article-title":"Recurrence after resection with curative intent for distal cholangiocarcinoma","volume":"104","author":"Komaya","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2024.107980_bib24","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1245\/s10434-020-08534-2","article-title":"Time to recurrence after surgical resection and survival after recurrence among patients with perihilar and distal cholangiocarcinomas","volume":"27","author":"Nakanishi","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2024.107980_bib25","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.3390\/cancers13194772","article-title":"Impact of body mass index on tumor recurrence in patients undergoing liver resection for perihilar cholangiocarcinoma (pCCA)","volume":"24","author":"Hau","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.107980_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/cncr.24766","article-title":"Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma","volume":"116","author":"Nagahashi","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2024.107980_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00423-015-1351-6","article-title":"Is it possible to define early distal cholangiocarcinoma?","volume":"401","author":"Miura","year":"2016","journal-title":"Langenbeck's Arch Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:21:44Z","timestamp":1780773704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0748798324000325"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.107980","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.107980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107980"}}